Hot Life Science Investor Mandate 1: Asia PE Firm Seeks East/West Life Science Opportunities

1 Oct

A global private equity and corporate finance advisory firm is headquartered in Singapore with offices in India, Malaysia and London. The firm makes global investments into life science companies as well as services related to healthcare. The firm leads the round with a $0.5m – $10m investment and utilizes their network to seek out other co-investors. The firm will occasionally seek distribution rights for international investments.

The PE firm is interested in therapeutics, medical devices, diagnostics, healthcare IT, biotech R&D services and suppliers and engineering companies. The firm is both stage and indication agnostic and has no revenue requirement. The firm has flexible investment criteria but the East West Axis is very important as the firm is not interested in companies that are restricted to one country; the firm only looks for companies with a multinational, global component.

The PE firm is flexible with their management team requirements. The firm is open to bringing in their own talent to assist with management and have assisted scientists in becoming successful entrepreneurs. The firm is a value-added investor driven by opportunity. The firm takes a board seat when making investments.

If you are interested in more information about this investor and other investors tracked by LSN, please email

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: